Ticker	Volume	Price	Price Delta
DJIA	15,303.10	+8.60	0.06%
S&P 500	1,649.60	-0.91	-0.06%
Nasdaq	3,459.14	-0.27	-0.01%

Ticker

Volume

Price

Price Delta

DJIA

15,303.10

+8.60

0.06%

S&P 500

1,649.60

-0.91

-0.06%

Nasdaq

3,459.14

-0.27

-0.01%

Ticker	Volume	Price	Price Delta
STOXX 50	2,764.29	-12.49	-0.45%
FTSE 100	6,654.34	-42.45	-0.63%
DAX	8,305.32	-46.66	-0.56%

Ticker

Volume

Price

Price Delta

STOXX 50

2,764.29

-12.49

-0.45%

FTSE 100

6,654.34

-42.45

-0.63%

DAX

8,305.32

-46.66

-0.56%

Ticker	Volume	Price	Price Delta
Nikkei	14,612.50	+128.47	0.89%
Hang Seng	22,618.70	-51.01	-0.23%
S&P/ASX 200	4,983.50	-78.95	-1.56%

Ticker

Volume

Price

Price Delta

Nikkei

14,612.50

+128.47

0.89%

Hang Seng

22,618.70

-51.01

-0.23%

S&P/ASX 200

4,983.50

-78.95

-1.56%

Linde to Fund Lincare Deal With $4.5 Billion Acquisition Loan

By Patricia Kuo - 2012-07-02T08:48:42Z

Linde AG (LIN), the world’s second-biggest maker of industrial gases, said it plans to fund the acquisition of Lincare Holdings Inc. (LNCR) with a $4.5 billion acquisition loan and existing cash.

The acquisition loan will be refinanced with a share sale of as much as 1.5 billion euros ($1.9 billion) and by other debt, the Munich, Germany-based company said in the statement. It will seek to maintain its current credit ratings of A by Standard & Poor’s and A3 by Moody’s Investors Service.

Linde said today it agreed to buy Lincare in Clearwater, Florida for about $4.6 billion including assumed debt. Lincare provides oxygen and respiratory therapy services.

To contact the reporter on this story: Patricia Kuo in London at pkuo2@bloomberg.net

To contact the editor responsible for this story: Faris Khan at fkhan33@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.